Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
about
Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiologyPGE2 is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells.Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity.In vivo rectal inflammatory mediator changes with radiotherapy to the pelvis.Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation.Immunoregulatory function of human intestinal mucosa lymphoid cells: evidence for enhanced suppressor cell activity in inflammatory bowel disease.Mechanism of chloride secretion induced by carbachol in a colonic epithelial cell lineEffects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.Effect of glucocorticoids on rectal transport in normal subjects and patients with ulcerative colitisUlcerative colitis--a disease characterised by the abnormal colonic epithelial cell?Chloride secretory mechanism induced by prostaglandin E1 in a colonic epithelial cell line.Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.Evaluation of new therapies for inflammatory bowel disease.Effect of olive oil on early and late events of colon carcinogenesis in rats: modulation of arachidonic acid metabolism and local prostaglandin E(2) synthesis.Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paperLoss of EP2 receptor subtype in colonic cells compromise epithelial barrier integrity by altering claudin-4Increased metabolism of arachidonic acid in an immune model of colitis in guinea-pigs.Regulation of smooth muscle contraction by the epithelium: role of prostaglandins.Ulcerative colitis: effect of sulphasalazine, its metabolites and indomethacin on the ability of human colonic mucosa to metabolize prostaglandins in vitro.Prostaglandins and ulcerative colitis.Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosaEstimation of phenolic conjugation by colonic mucosa.Inhibition of prostaglandin synthetase in human rectal mucosa.The effect of chlorpromazine on the function of colonic and ileal mucosa in the anaesthetized rat.Mechanism of action of 5-arninosalicylic acid.Source of endogenous arachidonate and 5-lipoxygenase products in human neutrophils stimulated by bradykinin and A23187.Electrolyte and acid-base disorders in inflammatory bowel disease.Role of EP4 receptor and prostaglandin transporter in prostaglandin E2-induced alteration in colonic epithelial barrier integrity.Increased suppressor cell activity in inflammatory bowel disease.Rectal potential differences in irritable bowel syndrome and in inflammatory bowel diseases in man.
P2860
Q28534532-774697B6-0C90-42F1-872F-52D9129C4B10Q28821807-C185A100-7C42-4E1C-9214-8A8363F9FDB2Q34022356-C7E46836-6D77-4444-AEC3-BFCEF5D16CA1Q34381244-3DCE371E-603D-4EF1-AB69-3274B9B769D5Q34391539-3F6EE632-D1EE-4ED6-B823-E1DAECCC5157Q34496477-2EAC6E14-E617-4EE6-AB0D-22733E6E7238Q34520348-522011F1-D7C6-4487-8467-3223C169C1F4Q34525348-1FA69E5C-14F4-4735-8455-62B8DA9FD94FQ34529329-5707284E-924C-417E-81A8-A8915286C2AEQ34529699-4A8711E9-BF62-437D-ACB5-DA09D8D02E33Q34564507-38A6A713-F2E6-45C7-817C-D2DC3E44C6FEQ34687708-4B6670AF-1D28-469B-8408-8D0E396FA449Q35216827-1F8AD218-063E-4304-B111-7785399BF2FFQ35359099-EAA85F4D-CE68-4EA5-8F54-27D15F694DCCQ35359745-D1B06B4B-5982-4EA2-8EE7-B202B6E9BD2BQ35420561-7A7A8FC5-36DA-450D-9676-9B4698388FDAQ35886654-EEB966E4-05A5-47E2-A735-73B3FAA8895DQ37888990-39AB4C13-760C-46FF-9C6C-D5A733085D05Q39856402-3A8ADDE0-57CD-4031-9C41-432053C3CF61Q40096108-D32470F1-1A91-4056-9EE5-03B86F487E22Q41868286-1F38E39C-EE34-4086-AE70-BD8228864549Q41953902-309BA29B-60B8-41B3-A135-773FFAFC8F97Q41983408-50A9B3D9-1805-489D-B6B3-AE7F79FA50A7Q42092649-0EF3DD15-9B9C-4F5D-AE24-01A203E14071Q42106723-6BAAE897-0566-479B-B66E-3C2AE00CE254Q42117190-E663A2BB-381C-4E54-B037-4A51556FF542Q42406557-3394245B-B6D0-4167-A7E0-56AE319495F2Q42919020-0BBC153C-ECD3-44E4-A07E-5B634DC82AB7Q43255584-36A7B313-1897-4D72-AE58-0E90AC1D3413Q43632807-B8061B37-08DA-4013-AF60-D1DAF6595D6A
P2860
Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@en
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@nl
type
label
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@en
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@nl
prefLabel
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@en
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@nl
P2093
P2860
P356
P1433
P1476
Rectal mucosal prostaglandin E ...... eatment in ulcerative colitis.
@en
P2093
P2860
P304
P356
10.1136/GUT.21.7.591
P407
P577
1980-07-01T00:00:00Z